Tom Anbergen
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Phagocytosis and Immune Regulation 2
- Immunotherapy and Immune Responses 2
- Immune responses and vaccinations 1
- Immune cells in cancer 1
-
- RNA Interference and Gene Delivery 1
- Extracellular vesicles in disease 1
- Co-authors
- Roy van der Meel (4 shared papers)Jeroen Deckers (3 shared papers)Willem J. M. Mulder (3 shared papers)Thijs J. Beldman (3 shared papers)Anne de Dreu (3 shared papers)David P. Schrijver (3 shared papers)Mihai G. Netea (2 shared papers)Francesca Grisoni (2 shared papers)
- Journals
- Nanomedicine (1 paper)Advanced Therapeutics (1 paper)Nature Reviews Bioengineering (2 papers)
- Partner nations
- NetherlandsUnited StatesRomania
In The Last Decade
Tom Anbergen
4 papers receiving 159 citations
Tom Anbergen's Hit Papers
Peers
Comparison fields: 5 of 51
- Immunology 73
- Oncology 38
- Biotechnology 10
- Biomaterials 11
- Genetics 20
Countries citing papers authored by Tom Anbergen
This map shows the geographic impact of Tom Anbergen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Anbergen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Anbergen more than expected).
Fields of papers citing papers by Tom Anbergen
This network shows the impact of papers produced by Tom Anbergen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Anbergen. The network helps show where Tom Anbergen may publish in the future.
Co-authors
The 17 scholars most cited alongside Tom Anbergen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Engineering cytokine therapeutics Hit paper breakdown → | 2023 | 145 |
| 2 | 2021 | 12 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 |
About Tom Anbergen
Tom Anbergen is a scholar working on Immunology, Molecular Biology, Oncology, Infectious Diseases and Organic Chemistry, having authored 4 papers that have together received 161 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (2 papers), Immunotherapy and Immune Responses (2 papers), Immune responses and vaccinations (1 paper), Immune cells in cancer (1 paper), CAR-T cell therapy research (1 paper), RNA Interference and Gene Delivery (1 paper) and Extracellular vesicles in disease (1 paper). The work is most often cited by research in Immunology (73 citations), Oncology (38 citations), Biotechnology (10 citations), Biomaterials (11 citations) and Genetics (20 citations). Tom Anbergen has collaborated with scholars based in Netherlands, United States and Romania. Frequent co-authors include Roy van der Meel, Jeroen Deckers, Willem J. M. Mulder, Thijs J. Beldman, Anne de Dreu, David P. Schrijver, Mihai G. Netea, Francesca Grisoni, Yohana C. Toner and Leo A. B. Joosten. Their work appears in journals such as Nanomedicine, Advanced Therapeutics and Nature Reviews Bioengineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.